THIAZOLIDINEDIONE COMPOUND
PROBLEM TO BE SOLVED: To provide a compound useful as a medicine, in particular as an insulin secretion promoter and a prophylactic and/or therapeutic agent for diseases associated with GPR40 such as diabetes.SOLUTION: The invention is accomplished based on a finding resulting from study on a compou...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | YOSHIDA SHIGERU NEGORO KENJI ONUKI KEI BEITOKU YASUHIRO KURAMOTO KAZUYUKI KUROSAKI TOSHIO IWASAKI FUMIYOSHI SOGA TAKATOSHI |
description | PROBLEM TO BE SOLVED: To provide a compound useful as a medicine, in particular as an insulin secretion promoter and a prophylactic and/or therapeutic agent for diseases associated with GPR40 such as diabetes.SOLUTION: The invention is accomplished based on a finding resulting from study on a compound having a GPR40 receptor agonist action, that a thiazolidinedione compound including thiazolidinedione binding to a 6-membered monocyclic aromatic ring via a carbon atom with the aromatic ring further binding to benzene substituted with a 6-membered monocyclic aromatic ring via a linker, and a salt thereof exhibit excellent GPR40 agonist activity. The thiazolidinedione compound can be used as an insulin secretion promoter, and a prophylactic and/or therapeutic agent for diabetes. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2011016722A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2011016722A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2011016722A3</originalsourceid><addsrcrecordid>eNrjZJAK8fB0jPL38XTx9HN18fT3c1Vw9vcN8A_1c-FhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfFeAUYGhoYGhmbmRkaOxkQpAgCIVyDZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>THIAZOLIDINEDIONE COMPOUND</title><source>esp@cenet</source><creator>YOSHIDA SHIGERU ; NEGORO KENJI ; ONUKI KEI ; BEITOKU YASUHIRO ; KURAMOTO KAZUYUKI ; KUROSAKI TOSHIO ; IWASAKI FUMIYOSHI ; SOGA TAKATOSHI</creator><creatorcontrib>YOSHIDA SHIGERU ; NEGORO KENJI ; ONUKI KEI ; BEITOKU YASUHIRO ; KURAMOTO KAZUYUKI ; KUROSAKI TOSHIO ; IWASAKI FUMIYOSHI ; SOGA TAKATOSHI</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a compound useful as a medicine, in particular as an insulin secretion promoter and a prophylactic and/or therapeutic agent for diseases associated with GPR40 such as diabetes.SOLUTION: The invention is accomplished based on a finding resulting from study on a compound having a GPR40 receptor agonist action, that a thiazolidinedione compound including thiazolidinedione binding to a 6-membered monocyclic aromatic ring via a carbon atom with the aromatic ring further binding to benzene substituted with a 6-membered monocyclic aromatic ring via a linker, and a salt thereof exhibit excellent GPR40 agonist activity. The thiazolidinedione compound can be used as an insulin secretion promoter, and a prophylactic and/or therapeutic agent for diabetes.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110127&DB=EPODOC&CC=JP&NR=2011016722A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25568,76551</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110127&DB=EPODOC&CC=JP&NR=2011016722A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YOSHIDA SHIGERU</creatorcontrib><creatorcontrib>NEGORO KENJI</creatorcontrib><creatorcontrib>ONUKI KEI</creatorcontrib><creatorcontrib>BEITOKU YASUHIRO</creatorcontrib><creatorcontrib>KURAMOTO KAZUYUKI</creatorcontrib><creatorcontrib>KUROSAKI TOSHIO</creatorcontrib><creatorcontrib>IWASAKI FUMIYOSHI</creatorcontrib><creatorcontrib>SOGA TAKATOSHI</creatorcontrib><title>THIAZOLIDINEDIONE COMPOUND</title><description>PROBLEM TO BE SOLVED: To provide a compound useful as a medicine, in particular as an insulin secretion promoter and a prophylactic and/or therapeutic agent for diseases associated with GPR40 such as diabetes.SOLUTION: The invention is accomplished based on a finding resulting from study on a compound having a GPR40 receptor agonist action, that a thiazolidinedione compound including thiazolidinedione binding to a 6-membered monocyclic aromatic ring via a carbon atom with the aromatic ring further binding to benzene substituted with a 6-membered monocyclic aromatic ring via a linker, and a salt thereof exhibit excellent GPR40 agonist activity. The thiazolidinedione compound can be used as an insulin secretion promoter, and a prophylactic and/or therapeutic agent for diabetes.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAK8fB0jPL38XTx9HN18fT3c1Vw9vcN8A_1c-FhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfFeAUYGhoYGhmbmRkaOxkQpAgCIVyDZ</recordid><startdate>20110127</startdate><enddate>20110127</enddate><creator>YOSHIDA SHIGERU</creator><creator>NEGORO KENJI</creator><creator>ONUKI KEI</creator><creator>BEITOKU YASUHIRO</creator><creator>KURAMOTO KAZUYUKI</creator><creator>KUROSAKI TOSHIO</creator><creator>IWASAKI FUMIYOSHI</creator><creator>SOGA TAKATOSHI</creator><scope>EVB</scope></search><sort><creationdate>20110127</creationdate><title>THIAZOLIDINEDIONE COMPOUND</title><author>YOSHIDA SHIGERU ; NEGORO KENJI ; ONUKI KEI ; BEITOKU YASUHIRO ; KURAMOTO KAZUYUKI ; KUROSAKI TOSHIO ; IWASAKI FUMIYOSHI ; SOGA TAKATOSHI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2011016722A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>YOSHIDA SHIGERU</creatorcontrib><creatorcontrib>NEGORO KENJI</creatorcontrib><creatorcontrib>ONUKI KEI</creatorcontrib><creatorcontrib>BEITOKU YASUHIRO</creatorcontrib><creatorcontrib>KURAMOTO KAZUYUKI</creatorcontrib><creatorcontrib>KUROSAKI TOSHIO</creatorcontrib><creatorcontrib>IWASAKI FUMIYOSHI</creatorcontrib><creatorcontrib>SOGA TAKATOSHI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YOSHIDA SHIGERU</au><au>NEGORO KENJI</au><au>ONUKI KEI</au><au>BEITOKU YASUHIRO</au><au>KURAMOTO KAZUYUKI</au><au>KUROSAKI TOSHIO</au><au>IWASAKI FUMIYOSHI</au><au>SOGA TAKATOSHI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>THIAZOLIDINEDIONE COMPOUND</title><date>2011-01-27</date><risdate>2011</risdate><abstract>PROBLEM TO BE SOLVED: To provide a compound useful as a medicine, in particular as an insulin secretion promoter and a prophylactic and/or therapeutic agent for diseases associated with GPR40 such as diabetes.SOLUTION: The invention is accomplished based on a finding resulting from study on a compound having a GPR40 receptor agonist action, that a thiazolidinedione compound including thiazolidinedione binding to a 6-membered monocyclic aromatic ring via a carbon atom with the aromatic ring further binding to benzene substituted with a 6-membered monocyclic aromatic ring via a linker, and a salt thereof exhibit excellent GPR40 agonist activity. The thiazolidinedione compound can be used as an insulin secretion promoter, and a prophylactic and/or therapeutic agent for diabetes.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_JP2011016722A |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | THIAZOLIDINEDIONE COMPOUND |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T08%3A43%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YOSHIDA%20SHIGERU&rft.date=2011-01-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2011016722A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |